Neuropathic pain is achronicconditionaffecting millionsof people worldwide, andcurrenttreatments are often inadequate, ineffective or associated with potential severeside effects.
And cash flow on the industrial side, stripped of the borrowed money passed through as a "dividend" from the finance side in years past, was down a reasonable 13% in 2009, given the worldwide financial meltdown.